CBD — Cannasouth Share Price
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -16.3% | ||
| Return on Equity | -29.26% | ||
| Operating Margin | -899.28% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | NZ$m | 0.05 | 0.13 | 0.21 | 0.14 | 0.96 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cannasouth Limited is a New Zealand-based medicinal cannabis company. The Company is a vertically integrated biopharmaceutical company dedicated to advanced product development and research. It produces cannabis-based medicines and ingredients using cannabinoid extracts from high-quality, medical-grade cultivars and holds end-to-end GMP licenses for the manufacturing of medicines including dried cannabis flower, CBD oral solutions, and pharmaceutical ingredients. It offers a suite of medicinal cannabis products, raw materials, and laboratory services for export markets, and the local medicinal cannabis markets. It provides a range of imported Cannasouth-branded medicinal cannabis products. It also offers an online clinic, and related activities, such as research and development, marketing, and sales. Its subsidiaries include Eqalis Pharmaceuticals Limited, Eqalis Innovation Limited, Cannasouth Bioscience Limited, RestoreMe Clinic Limited, Cannasouth Cultivation Limited, and others.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 21st, 2018
- Public Since
- June 19th, 2019
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- New Zealand Stock Exchange
- Shares in Issue
- 330,470,590
- Address
- 240 Victoria Street, Hamilton, 3216
- Web
- https://www.cannasouth.co.nz/
- Phone
- +64 79498393
- Auditors
- RSM Hayes Audit
Upcoming Events for CBD
Similar to CBD
Pacific Edge
New Zealand Stock Exchange
FAQ
What is the Cannasouth share price?
As of Today at 18:45 UTC, shares in Cannasouth are trading at NZ$0.10. This share price information is delayed by 15 minutes.
How has the Cannasouth share price performed this year?
Shares in Cannasouth last closed at NZ$0.10 and the price had moved by -66.78% over the past 365 days. In terms of relative price strength the Cannasouth share price has underperformed the ASX All Ordinaries Index by -70.47% over the past year.
What are the analyst and broker recommendations for Cannasouth?
There is no consensus recommendation for this security.
Find out moreWhat is the Cannasouth dividend yield?
Cannasouth does not currently pay a dividend.
Does Cannasouth pay a dividend?
Cannasouth does not currently pay a dividend.
When does Cannasouth next pay dividends?
Cannasouth does not currently pay a dividend.
How do I buy Cannasouth shares?
To buy shares in Cannasouth you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Cannasouth?
As of the previous close price of NZ$0.10, shares in Cannasouth had a market capitalisation of .
Where are Cannasouth shares listed?
Here are the trading details for Cannasouth:
- Country of listing: New Zealand
- Exchange: NZC
- Ticker Symbol: CBD
What kind of share is Cannasouth?
Based on an overall assessment of its quality, value and momentum Cannasouth is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Cannasouth share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Cannasouth share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cannasouth. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -53.31%.
As of the last closing price of NZ$0.10, shares in Cannasouth were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Cannasouth PE Ratio?
The Cannasouth PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at NZ$0.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Cannasouth?
We do not have data on Cannasouth's directors